Cover Image
市場調查報告書

生命科學BPO的全球市場分析:各類服務 (醫藥品外包,醫療設備外包,受託營業,行銷外包),市場區隔預測

Life Sciences BPO Market Analysis by Services (Pharmaceutical Outsourcing, Medical Devices Outsourcing, Contract Sales, Marketing Outsourcing), and Segment Forecasts to 2024

出版商 Grand View Research, Inc. 商品編碼 368007
出版日期 內容資訊 英文 92 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
生命科學BPO的全球市場分析:各類服務 (醫藥品外包,醫療設備外包,受託營業,行銷外包),市場區隔預測 Life Sciences BPO Market Analysis by Services (Pharmaceutical Outsourcing, Medical Devices Outsourcing, Contract Sales, Marketing Outsourcing), and Segment Forecasts to 2024
出版日期: 2016年07月24日 內容資訊: 英文 92 Pages
簡介

本報告提供全球生命科學BPO市場相關調查,彙整產業預測,以及各類服務,各地區趨勢,及打入市場的主要企業簡介等資料。

第1章 摘要整理

第2章 市場概要

第3章 市場變動,趨勢,範圍

  • 市場區隔和範圍
    • 推動市場的要素分析
    • 阻礙市場的要素分析
  • 簡報及成長預測製圖
  • SWOT分析
  • 波特產業分析

第4章 市場分類1:服務預測與趨勢分析

  • 服務趨勢分析
  • 醫藥品外包
  • 醫療設備外包
  • 受託營業及行銷組織
  • 其他

第5章 市場分類2:各地區預測與趨勢分析

  • 各地區市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第6章 競爭環境

  • 策略性架構
  • 市場進入分類
  • 企業簡介
    • Anthelio Healthcare Solutions
    • Boehringer Ingelheim GmbH
    • Catalent, Inc.
    • Covance, Inc.
    • Genpact Limited
    • ICON plc
    • Infosys Limited
    • International Business Machines Corporation
    • Lonza Group
    • PAREXEL International Corporation
    • Quintiles Transnational Corporation
    • Accenture plc
    • Wipro Limited
    • Cognizant Technology Solutions

圖表

目錄

The life sciences BPO market is expected to reach USD 420 billion by 2024, according to a new report by Grand View Research, Inc. The lucrative growth is attributed to the growing demand for contract manufacturing of raw materials, Finished Dosage Forms (FDFs), medical devices, drug discovery services, regulatory services, pre-clinical and clinical trial services, and pharmacovigilance services.

The pharmaceutical and biotech industry invests heavily in the R&D sector to continuously introduce new molecules, devices, and treatments. The different stages of the drug development such as drug discovery, pre-clinical studies, and clinical trials require huge financial, technological, and human resources.

In order to cater to the growing needs of the industry, the outsourcing vendors are expanding their product and service offerings and they are targeting niche areas for long-term growth and profitability; altogether these trends are expected to boost the life sciences outsourcing market over the forecast period.

Favorable government initiatives such as the introduction of ICD-10 standards, the increasing adoption of Electronic Health Record systems (EHR), and digital health platforms are enabling the rapid growth of the back-end payer and provider BPO services, such as claims management, claims processing, financial and pay roll management, and other administrative services.

The rising geriatric population coupled with the growing prevalence of various chronic diseases is increasing the burden on the healthcare system and also driving the need for new drugs, and devices, which in turn is expected to boost the contract manufacturing and contract research services over the next nine years.

Moreover, the contract sales and marketing services segments are also expected to witness an increase in demand due to the growing sales and marketing activities for the new product launches over the forecast period.

Further key findings from the study suggest:

In 2015, the pharmaceutical outsourcing segment accounted for the largest revenue share, mainly on account of the growing demand for API and finished dosage form manufacturing services. Moreover, the increasing demand for early stage pre-clinical studies, clinical trials, post-marketing surveillance, and regulatory services are also expected to further drive the market over the forecast period.

The services segment including healthcare payer and provider BPO services is expected to emerge as the fastest growing services type with a CAGR of 9.3% over the forecast period.

In the medical devices contract research outsourcing segment, the product design and development category accounted for nearly 29% in 2015. By 2024, the product implementation services are expected to emerge as the fastest growing category with a CAGR of 13.1% from 2016 to 2024.

North America was the largest regional market in 2015. The presence of several major pharmaceuticals, medical device, health insurance, contract research and contract manufacturing (CRAMS) players in this region are amongst the key factors responsible for the region's large market share. The increasing geriatric population, the growing disease prevalence rates, the shift from ICD 9 to ICD 10 codes are significantly driving the healthcare expenditures and the need for efficient data management, as well as operational costs; therefore, these factors are expected to positively reinforce the life sciences outsourcing market over the forecast period.

Asia Pacific is expected to grow at a CAGR of11% over the forecast period. The increase in the number of U.S. FDA manufacturing sites in this region, especially China and India, the growing healthcare burden, patent expiration of several key drugs are expected to significantly boost the life sciences outsourcing market in this region.

Furthermore, favorable government initiatives to encourage the use of generic drugs, subsidies for the manufacturing of electronic components and devices, and several tax benefits to promote the export of life sciences services from this region are anticipated to further propel the market growth over the forecast period.

Some key market players include Infosys Limited, Lonza Group, PAREXEL International Corporation, Covance, Inc., International Business Machines Corporation. Genpact Limited, Catalent, Inc., ICON plc, Boehringer Ingelheim GmbH, Accenture plc, Quintiles Transnational Corporation, and Anthelio Healthcare Solutions.

Table of Contents

Chapter 1: Executive Summary

Chapter 2: Market Snapshot

Chapter 3: Market Variables, Trends & Scope

  • 3.1 Market Segmentation & Scope
    • 3.1.1 Market Driver Analysis
      • 3.1.1.2 Growing demand for orphan drug discovery
      • 3.1.1.3 Increasing incidences of M&A of CDMO/CRO with big pharma companies
    • 3.1.2 Market Restraint Analysis
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Life sciences BPO - SWOT Analysis, By Factor (political & legal, economic and technological)
  • 3.4 Industry Analysis - Porter's

Chapter 4: Market Categorization 1: Services Estimates & Trend Analysis

  • 4.1 Life sciences BPO Market: service movement analysis
  • 4.2 Pharmaceutical outsourcing
    • 4.2.1 Pharmaceutical outsourcing market estimates, 2013 - 2015 (USD Billion)
    • 4.2.2 Pharmaceutical outsourcing Market Forecasts, 2016 - 2024 (USD Billion)
    • 4.2.3 Contract Manufacturing
      • 4.2.3.1 Contract manufacturing market estimates, 2013 - 2015 (USD Billion)
      • 4.2.3.2 Contract manufacturing market forecasts, 2016 - 2024 (USD Billion)
      • 4.2.3.3 Active Pharmaceutical Ingredients
      • 4.2.3.3.1 Active pharmaceutical ingredients market estimates, 2013 - 2015 (USD Billion)
      • 4.2.3.3.2 Active pharmaceutical ingredients market forecasts, 2016 - 2024 (USD Billion)
      • 4.2.3.4 Finished Dose Form
      • 4.2.3.4.1 Finished dose form market estimates, 2013 - 2015 (USD Billion)
      • 4.2.3.4.2 Finished dose form market forecasts, 2016 - 2024 (USD Billion)
      • 4.2.3.5 Packaging
      • 4.2.3.5.1 Packagingmarket estimates, 2013 - 2015 (USD Billion)
      • 4.2.3.5.2 Packagingmarket forecasts, 2016 - 2024 (USD Billion)
    • 4.2.4 Contract Research Organizations
      • 4.2.4.1 Contract research organizations market estimates, 2013 - 2015 (USD Billion)
      • 4.2.4.2 Contract research organizations market forecasts, 2016 - 2024 (USD Billion)
      • 4.2.4.3 Drug Discovery
      • 4.2.4.3.1 Drug discovery market estimates, 2013 - 2015 (USD Billion)
      • 4.2.4.3.2 Drug discovery market forecasts, 2016 - 2024 (USD Billion)
      • 4.2.4.4 Preclinical Studies
      • 4.2.4.4.1 Preclinical studies market estimates, 2013 - 2015 (USD Billion)
      • 4.2.4.4.2 Preclinical studies market forecasts, 2016 - 2024 (USD Billion)
      • 4.2.4.5 Clinical Trial Studies
      • 4.2.4.5.1 Clinical trial studies market estimates, 2013 - 2015 (USD Billion)
      • 4.2.4.5.2 Clinical trial studies market forecasts, 2016 - 2024 (USD Billion)
      • 4.2.4.6 Pharmacovigilance
      • 4.2.4.6.1 Pharmacovigilancemarket estimates, 2013 - 2015 (USD Billion)
      • 4.2.4.6.2 Pharmacovigilancemarket forecasts, 2016 - 2024 (USD Billion)
      • 4.2.4.7 Regulatory Services
      • 4.2.4.7.1 Regulatory services market estimates, 2013 - 2015 (USD Billion)
      • 4.2.4.7.2 Regulatory services market forecasts, 2016 - 2024 (USD Billion)
  • 4.3 Medical Devices Outsourcing
    • 4.3.1 Medical devicesoutsourcing market estimates, 2013 - 2015 (USD Billion)
    • 4.3.2 Medical devices outsourcing market forecasts, 2016 - 2024 (USD Billion)
    • 4.3.3 Contract Manufacturing Services
      • 4.3.3.1 Contract manufacturing services market estimates, 2013 - 2015 (USD Billion)
      • 4.3.3.2 Contract manufacturing services market forecasts, 2016 - 2024 (USD Billion)
      • 4.3.3.3 Electronic Manufacturing Services
      • 4.3.3.3.1 Electronic manufacturing services market estimates, 2013 - 2015 (USD Billion)
      • 4.3.3.3.2 Electronic manufacturing services market forecasts, 2016 - 2024 (USD Billion)
      • 4.3.3.4 Finished Goods
      • 4.3.3.4.1 Finished goods market estimates, 2013 - 2015 (USD Billion)
      • 4.3.3.4.2 Finished goods market forecasts, 2016 - 2024 (USD Billion)
      • 4.3.3.5 Raw Materials/Components
      • 4.3.3.5.1 Raw Materials/Components market estimates, 2013 - 2015 (USD Billion)
      • 4.3.3.5.2 Raw Materials/Components market forecasts, 2016 - 2024 (USD Billion)
    • 4.3.4 Regulatory Consulting Services
      • 4.3.4.1 Regulatory consulting services market estimates, 2013 - 2015 (USD Billion)
      • 4.3.4.2 Regulatory consulting services market forecasts, 2016 - 2024 (USD Billion)
    • 4.3.5 Product Design and Development Services
      • 4.3.5.1 Product design and development services market estimates, 2013 - 2015 (USD Billion)
      • 4.3.5.2 Product design and development services market forecasts, 2016 - 2024 (USD Billion)
    • 4.3.6 Product Testing Services
      • 4.3.6.1 Product testing services market estimates, 2013 - 2015 (USD Billion)
      • 4.3.6.2 Product testing services market forecasts, 2016 - 2024 (USD Billion)
    • 4.3.7 Product Implementation Services
      • 4.3.7.1 Product implementation services market estimates, 2013 - 2015 (USD Billion)
      • 4.3.7.2 Product implementation services market forecasts, 2016 - 2024 (USD Billion)
    • 4.3.8 Product Upgrade Services
      • 4.3.8.1 Product upgrade services market estimates, 2013 - 2015 (USD Billion)
      • 4.3.8.2 Product upgrade services market forecasts, 2016 - 2024 (USD Billion)
    • 4.3.9 Product Maintenance Services
      • 4.3.9.1 Product maintenance services market estimates, 2013 - 2015 (USD Billion)
      • 4.3.9.2 Product maintenance services market forecasts, 2016 - 2024 (USD Billion)
  • 4.4 Contract Sales and Marketing Organization
    • 4.4.1 Contract sales and marketing organizationmarket estimates, 2013 - 2015 (USD Billion)
    • 4.4.2 Contract sales and marketing organizationmarket forecasts, 2016 - 2024 (USD Billion)
  • 4.5 Others (Payers and Providers)
    • 4.5.1 Others (payers and providers) market estimates, 2013 - 2015 (USD Billion)
    • 4.5.2 Others (payers and providers) market forecasts, 2016 - 2024 (USD Billion)

Chapter 5: Market Categorization 3: Regional Estimates & Trend Analysis, by Product & Application

  • 5.1 Life sciences BPO Market share by region, 2013 & 2020
  • 5.2 North America
    • 5.2.1 North America life sciences BPO market estimates, by services 2013 - 2015 (USD Billion)
    • 5.2.2 North America life sciences BPO market forecasts, by services 2016 - 2024 (USD Billion)
    • 5.2.3 U.S.
    • 5.2.4 U.S. life sciences BPO market estimates, by services 2013 - 2015 (USD Billion)
    • 5.2.5 U.S. life sciences BPO market forecasts, by services 2016 - 2024 (USD Billion)
    • 5.2.6 Canada
    • 5.2.7 Canada life sciences BPO market estimates, by services 2013 - 2015 (USD Billion)
    • 5.2.8 Canada life sciences BPO market forecasts, by services 2016 - 2024 (USD Billion)
  • 5.3 Europe
    • 5.3.1 Europe life sciences BPO market estimates, by services 2013 - 2015 (USD Billion)
    • 5.3.2 Europe life sciences BPO market forecasts, by services 2016 - 2024 (USD Billion)
    • 5.3.3 Germany
    • 5.3.4 Germany life sciences BPO market estimates, by services 2013 - 2015 (USD Billion)
    • 5.3.5 Germany life sciences BPO market forecasts, by services 2016 - 2024 (USD Billion)
    • 5.3.6 UK
    • 5.3.7 UK life sciences BPO market estimates, by services 2013 - 2015 (USD Billion)
    • 5.3.8 UK life sciences BPO market forecasts, by services 2016 - 2024 (USD Billion)
  • 5.4 Asia-Pacific
    • 5.4.1 Asia-Pacific life sciences BPO market estimates, by services 2013 - 2015 (USD Billion)
    • 5.4.2 Asia-Pacific life sciences BPO market forecasts, by services 2016 - 2024 (USD Billion)
    • 5.4.3 Japan
    • 5.4.4 Japan life sciences BPO market estimates, by services 2013 - 2015 (USD Billion)
    • 5.4.5 Japan life sciences BPO market forecasts, by services 2016 - 2024 (USD Billion)
    • 5.4.6 China
    • 5.4.7 China life sciences BPO market estimates, by services 2013 - 2015 (USD Billion)
    • 5.4.8 China life sciences BPO market forecasts, by services 2016 - 2024 (USD Billion)
    • 5.4.9 India
    • 5.4.10 India life sciences BPO market estimates, by services 2013 - 2015 (USD Billion)
    • 5.4.11 India life sciences BPO market forecasts, by services 2016 - 2024 (USD Billion)
  • 5.5 Latin America
    • 5.5.1 Latin America life sciences BPO market estimates, by services 2013 - 2015 (USD Billion)
    • 5.5.2 Latin America life sciences BPO market forecasts, by services 2016 - 2024 (USD Billion)
    • 5.5.3 Brazil
    • 5.5.4 Brazil life sciences BPO market estimates, by services 2013 - 2015 (USD Billion)
    • 5.5.5 Brazil life sciences BPO market forecasts, by services 2016 - 2024 (USD Billion)
    • 5.5.6 Mexico
    • 5.5.7 Mexico life sciences BPO market estimates, by services 2013 - 2015 (USD Billion)
    • 5.5.8 Mexico life sciences BPO market forecasts, by services 2016 - 2024 (USD Billion)
  • 5.6 MEA
    • 5.6.1 MEA life sciences BPO market estimates, by services 2013 - 2015 (USD Billion)
    • 5.6.2 MEA life sciences BPO market forecasts, by services 2016 - 2024 (USD Billion)
    • 5.6.3 South Africa
    • 5.6.4 South Africa life sciences BPO market estimates, by services 2013 - 2015 (USD Billion)
    • 5.6.5 South Africa life sciences BPO market forecasts, by services 2016 - 2024 (USD Billion)

Chapter 6: Competitive Landscape

  • 6.1 Strategy Framework
  • 6.2 Market Participation Categorization
  • 6.3 Company Profiles
    • 6.3.1 Anthelio Healthcare Solutions
      • 6.3.1.1 Company Overview
      • 6.3.1.2 Financial Performance
      • 6.3.1.3 Product Benchmarking
      • 6.3.1.4 Strategic Initiatives
    • 6.3.2 Boehringer Ingelheim GmbH
      • 6.3.2.1 Company Overview
      • 6.3.2.2 Financial Performance
      • 6.3.2.3 Product Benchmarking
      • 6.3.2.4 Strategic Initiatives
    • 6.3.3 Catalent, Inc.
      • 6.3.3.1 Company Overview
      • 6.3.3.2 Financial Performance
      • 6.3.3.3 Product Benchmarking
      • 6.3.3.4 Strategic Initiatives
    • 6.3.4 Covance, Inc.
      • 6.3.4.1 Company Overview
      • 6.3.4.2 Financial Performance
      • 6.3.4.3 Product Benchmarking
      • 6.3.4.4 Strategic Initiatives
    • 6.3.5 Genpact Limited
      • 6.3.5.1 Company Overview
      • 6.3.5.2 Financial Performance
      • 6.3.5.3 Product Benchmarking
      • 6.3.5.4 Strategic Initiatives
    • 6.3.6 ICON plc
      • 6.3.6.1 Company Overview
      • 6.3.6.2 Financial Performance
      • 6.3.6.3 Product Benchmarking
      • 6.3.6.4 Strategic Initiatives
    • 6.3.7 Infosys Limited
      • 6.3.7.1 Company Overview
      • 6.3.7.2 Financial Performance
      • 6.3.7.3 Product Benchmarking
      • 6.3.7.4 Strategic Initiatives
    • 6.3.8 International Business Machines Corporation
      • 6.3.8.1 Company Overview
      • 6.3.8.2 Financial Performance
      • 6.3.8.3 Product Benchmarking
      • 6.3.8.4 Strategic Initiatives
    • 6.3.9 Lonza Group
      • 6.3.9.1 Company Overview
      • 6.3.9.2 Financial Performance
      • 6.3.9.3 Product Benchmarking
      • 6.3.9.4 Strategic Initiatives
    • 6.3.10 PAREXEL International Corporation
      • 6.3.10.1 Company Overview
      • 6.3.10.2 Financial Performance
      • 6.3.10.3 Product Benchmarking
      • 6.3.10.4 Strategic Initiatives
    • 6.3.11 Quintiles Transnational Corporation
      • 6.3.11.1 Company Overview
      • 6.3.11.2 Financial Performance
      • 6.3.11.3 Product Benchmarking
      • 6.3.11.4 Strategic Initiatives
    • 6.3.12 Accenture plc
      • 6.3.12.1 Company Overview
      • 6.3.12.2 Financial Performance
      • 6.3.12.3 Product Benchmarking
      • 6.3.12.4 Strategic Initiatives
    • 6.3.13 Wipro Limited
      • 6.3.13.1 Company Overview
      • 6.3.13.2 Financial Performance
      • 6.3.13.3 Product Benchmarking
      • 6.3.13.4 Strategic Initiatives
    • 6.3.14 Cognizant Technology Solutions
      • 6.3.14.1 Company Overview
      • 6.3.14.2 Financial Performance
      • 6.3.14.3 Product Benchmarking
      • 6.3.14.4 Strategic Initiatives

List of Tables

  • TABLE 1: Global life sciences BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 2: Global pharmaceutical BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 3: Global pharmaceutical contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 4: Global pharmaceutical contract research organizations market, by services, 2013 - 2024 (USD Billion)
  • TABLE 5: Global medical devices BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 6: Global medical devices contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 7: Global medical devices CRO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 8: North America life sciencesBPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 9: North America pharmaceutical BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 10: North America pharmaceutical contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 11: North America pharmaceutical contract research organizations market, by services, 2013 - 2024 (USD Billion)
  • TABLE 12: North America medical devices BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 13: North America medical devices contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 14: North America medical devices CRO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 15: U.S. life sciencesBPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 16: U.S. pharmaceutical BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 17: U.S. pharmaceutical contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 18: U.S. pharmaceutical contract research organizations market, by services, 2013 - 2024 (USD Billion)
  • TABLE 19: U.S. medical devices BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 20: U.S. medical devices contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 21: U.S. medical devices CRO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 22: Canada life sciences BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 23: Canada pharmaceutical BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 24: Canada pharmaceutical contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 25: Canada pharmaceutical contract research organizations market, by Services, 2013 - 2024 (USD Billion)
  • TABLE 26: Canada medical devices BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 27: Canada medical devices contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 28: Canada medical devices CRO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 29: Europe life sciences BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 30: Europe pharmaceutical BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 31: Europe pharmaceutical contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 32: Europe pharmaceutical contract research organizations market, by services, 2013 - 2024 (USD Billion)
  • TABLE 33: Europe medical devices BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 34: Europe medical devices contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 35: Europe medical devices CRO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 36: Germany life sciences BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 37: Germany pharmaceutical BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 38: Germany pharmaceutical contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 39: Germany pharmaceutical contract research organizations market, by services, 2013 - 2024 (USD Billion)
  • TABLE 40: Germany medical devices BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 41: Germany medical devices contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 42: Germany medical devices CRO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 43: UK life sciences BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 44: UK pharmaceutical BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 45: UK pharmaceutical contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 46: UK pharmaceutical contract research organizations market, by services, 2013 - 2024 (USD Billion)
  • TABLE 47: UK medical devices BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 48: UK medical devices contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 49: UK medical devices CRO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 50: Asia-Pacific life sciences BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 51: Asia-Pacific pharmaceutical BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 52: Asia-Pacific pharmaceutical contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 53: Asia-Pacific pharmaceutical contract research organizations market, by services, 2013 - 2024 (USD Billion)
  • TABLE 54: Asia-Pacific medical devices BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 55: Asia-Pacific medical devices contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 56: Asia-Pacific medical devices CRO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 57: Japan life sciences BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 58: Japan pharmaceutical BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 59: Japan pharmaceutical contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 60: Japan pharmaceutical contract research organizations market, by services, 2013 - 2024 (USD Billion)
  • TABLE 61: Japan medical devices BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 62: Japan medical devices contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 63: Japan medical devices CRO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 64: China life sciences BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 65: China pharmaceutical BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 66: China pharmaceutical contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 67: China pharmaceutical contract research organizations market, by services, 2013 - 2024 (USD Billion)
  • TABLE 68: China medical devices BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 69: China medical devices contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 70: China medical devices CRO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 71: India life sciences BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 72: India pharmaceutical BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 73: India pharmaceutical contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 74: India pharmaceutical contract research organizations market, by services, 2013 - 2024 (USD Billion)
  • TABLE 75: India medical devices BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 76: India medical devices contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 77: India medical devices CRO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 78: Latin America life sciences BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 79: Latin America pharmaceutical BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 80: Latin America pharmaceutical contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 81: Latin America pharmaceutical contract research organizations market, by services, 2013 - 2024 (USD Billion)
  • TABLE 82: Latin America medical devices BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 83: Latin America medical devices contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 84: Latin America medical devices CRO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 85: Brazil life sciences BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 86: Brazil pharmaceutical BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 87: Brazil pharmaceutical contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 88: Brazil pharmaceutical contract research organizations market, by services, 2013 - 2024 (USD Billion)
  • TABLE 89: Brazil medical devices BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 90: Brazil medical devices contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 91: Brazil medical devices CRO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 92: Mexico life sciences BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 93: Mexico America pharmaceutical BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 94: Mexico pharmaceutical contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 95: Mexico pharmaceutical contract research organizations market, by services, 2013 - 2024 (USD Billion)
  • TABLE 96: Mexico medical devices BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 97: Mexico medical devices contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 98: Mexico medical devices CRO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 99: MEA life sciences BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 100: MEA pharmaceutical BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 101: MEA pharmaceutical contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 102: MEA pharmaceutical contract research organizations market, by services, 2013 - 2024 (USD Billion)
  • TABLE 103: MEA medical devices BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 104: MEA medical devices contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 105: MEA medical devices CRO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 106: South Africa life sciences BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 107: South Africa pharmaceutical BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 108: South Africa pharmaceutical contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 109: South Africa pharmaceutical contract research organizations market, by services, 2013 - 2024 (USD Billion)
  • TABLE 110: South Africa medical devices BPO market, by services, 2013 - 2024 (USD Billion)
  • TABLE 111: South Africa medical devices contract manufacturing market, by services, 2013 - 2024 (USD Billion)
  • TABLE 112: South Africa medical devices CRO market, by services, 2013 - 2024 (USD Billion)
Back to Top